reports
Care Property Invest: 1 director
A director at Care Property Invest bought 2,500 shares at 13.640EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Merus hält einen Vortrag auf der BofA Securities 2025 Health Care Conf...
Merus hält einen Vortrag auf der BofA Securities 2025 Health Care Conference UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, May 08, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: MRUS), ein Onkologieunternehmen, das innovative, multispezifische Antikörper in voller Länge (Biclonics® und Triclonics®) entwickelt, hat heute bekanntgegeben, dass Dr. Bill Lundberg, President und Chief Executive Officer von Merus, an einem Kamingespräch auf der BofA Securities 2025 Health Care Conference am Donnerstag, 15. Mai 2025, um 8:40 Uhr PT/11:40 Uhr ET teilnehmen wird. Der Webcast der Präsentation wird zeit...
Merus participera à la conférence BofA Securities 2025 sur les soins d...
Merus participera à la conférence BofA Securities 2025 sur les soins de santé UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachussets, 08 mai 2025 (GLOBE NEWSWIRE) -- (Nasdaq : MRUS), entreprise spécialisée en oncologie développant des anticorps de pleine longueur multispécifiques (Biclonics® et Triclonics®), a annoncé aujourd’hui que le Dr Bill Lundberg, Président et PDG de Merus, participera à une discussion informelle lors de la conférence BofA Securities 2025 sur les soins de santé, qui se tiendra le mardi 15 mai 2025 à 8h40 heure du Pacifique et à 11h40 heure de l’Est. Le webcast d...
Merus to Present at BofA Securities 2025 Health Care Conference
Merus to Present at BofA Securities 2025 Health Care Conference UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: MRUS), an oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on Thursday, May 15, 2025 at 8:40 a.m. PT/11:40 a.m. ET. The webcast of the presentation will be contemporaneously available on the of the Company'...
- Martin Marandon-Carlhian
- Stephane Houri
IFX INFINEON TECHNOLOGIES AG
LR LEGRAND
VIE VEOLIA ENVIRONNEMENT SA
TKA THYSSENKRUPP AG
MT ARCELORMITTAL SA
JMT JERONIMO MARTINS SGPS S.A.
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
G1A GEA GROUP AG
APAML APERAM SA
PUM PUMA SE
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
ADEN ADECCO GROUP AG
RHM RHEINMETALL AG
SZG SALZGITTER AG
VOE VOESTALPINE AG
ACX ACERINOX SA
ELE ENDESA S.A.
ORSTED ORSTED
FRE FRESENIUS SE & CO. KGAA
HEI HEIDELBERGCEMENT AG
ERA ERAMET SA
NDA AURUBIS AG
ARCAD ARCADIS NV
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
EDW EDP RENOVAVEIS SA
TIT TELECOM ITALIA S.P.A.
POST OSTERREICHISCHE POST AG
PRY PRYSMIAN S.P.A.
ABI ANHEUSER-BUSCH INBEV SA/NV
RIO RIO TINTO PLC
BHP BHP GROUP LTD
ARGX ARGEN-X SE
AMAG AMAG AUSTRIA METALL AG
KBX KNORR-BREMSE AG
IHG INTERCONTINENTAL HOTELS GROUP PLC
NEXI NEXI S.P.A.
ENR SIEMENS ENERGY AG
CTPNV CTP NV
ARM ARM HOLDINGS PLC
QGEN QIAGEN N.V.
- Olfa Taamallah
- Yan Derocles
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
LEI LEIFHEIT AG
ARYN ARYZTA AG
SCR SCOR SE
SZG SALZGITTER AG
LXS LANXESS AG
VOE VOESTALPINE AG
ACX ACERINOX SA
BAMNB KONINKLIJKE BAM GROEP NV
SOLB SOLVAY SA
ERA ERAMET SA
LNZ LENZING AG
COR CORTICEIRA AMORIM SGPS SA
NDA AURUBIS AG
CIE CIE AUTOMOTIVE S.A.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
SSO SCATEC ASA
POST OSTERREICHISCHE POST AG
GCO GRUPO CATALANA OCCIDENTE S.A.
SMHN SUESS MICROTEC AG
DIC DIC ASSET AG
RIO RIO TINTO PLC
BHP BHP GROUP LTD
AMAG AMAG AUSTRIA METALL AG
INS INSTONE REAL ESTATE GROUP AG
HAG HENSOLDT AG
SFQ SAF-HOLLAND SE
AERO MONTANA AEROSPACE AG
YOU ABOUT YOU HLDG AG
CTPNV CTP NV
ADTN ADTRAN HOLDINGS INC
ACAG AUSTRIACARD HOLDINGS AG
SHA SCHAEFFLER AG
- Martin Marandon-Carlhian
- Stephane Houri
IFX INFINEON TECHNOLOGIES AG
LR LEGRAND
VIE VEOLIA ENVIRONNEMENT SA
TKA THYSSENKRUPP AG
MT ARCELORMITTAL SA
JMT JERONIMO MARTINS SGPS S.A.
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
G1A GEA GROUP AG
APAML APERAM SA
PUM PUMA SE
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
ADEN ADECCO GROUP AG
RHM RHEINMETALL AG
SZG SALZGITTER AG
VOE VOESTALPINE AG
ACX ACERINOX SA
ELE ENDESA S.A.
ORSTED ORSTED
FRE FRESENIUS SE & CO. KGAA
HEI HEIDELBERGCEMENT AG
ERA ERAMET SA
NDA AURUBIS AG
ARCAD ARCADIS NV
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
EDW EDP RENOVAVEIS SA
TIT TELECOM ITALIA S.P.A.
PRY PRYSMIAN S.P.A.
ABI ANHEUSER-BUSCH INBEV SA/NV
RIO RIO TINTO PLC
BHP BHP GROUP LTD
ARGX ARGEN-X SE
AMAG AMAG AUSTRIA METALL AG
KBX KNORR-BREMSE AG
IHG INTERCONTINENTAL HOTELS GROUP PLC
NEXI NEXI S.P.A.
ENR SIEMENS ENERGY AG
CTPNV CTP NV
ARM ARM HOLDINGS PLC
QGEN QIAGEN N.V.
- Olfa Taamallah
- Yan Derocles
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
LEI LEIFHEIT AG
ARYN ARYZTA AG
SCR SCOR SE
SZG SALZGITTER AG
LXS LANXESS AG
VOE VOESTALPINE AG
ACX ACERINOX SA
BAMNB KONINKLIJKE BAM GROEP NV
SOLB SOLVAY SA
ERA ERAMET SA
LNZ LENZING AG
COR CORTICEIRA AMORIM SGPS SA
NDA AURUBIS AG
CIE CIE AUTOMOTIVE S.A.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
SSO SCATEC ASA
POST OSTERREICHISCHE POST AG
GCO GRUPO CATALANA OCCIDENTE S.A.
SMHN SUESS MICROTEC AG
DIC DIC ASSET AG
RIO RIO TINTO PLC
BHP BHP GROUP LTD
AMAG AMAG AUSTRIA METALL AG
INS INSTONE REAL ESTATE GROUP AG
HAG HENSOLDT AG
SFQ SAF-HOLLAND SE
AERO MONTANA AEROSPACE AG
YOU ABOUT YOU HLDG AG
ADTN ADTRAN HOLDINGS INC
ACAG AUSTRIACARD HOLDINGS AG
SHA SCHAEFFLER AG
- Damien Choplain
- Martial Descoutures
- Damien Choplain
- Martial Descoutures
- Robert Jan Vos
- Roy Külter
- Steven Boumans
- ING Helpdesk
Benelux Morning Notes
AB InBev: Strong brew. Adecco: 1Q25 beats on timing of JV income; 2Q25 outlook momentum positive. Alfen: Preview - 1Q25 should arrive in line. AMG: Strong 1Q25 EBITDA beat, guidance raised. BAM Group: Non-residential backs EBITDA increase. CTP: Strong results combined with strong message on demand dynamics. JDE Peet's: Jumping Beans. Kinepolis: Peer AMC 1Q25 results - revenues per visitor more subdued. Prosus: CEO letter highlights strong profit growth in 2026. Proximus: CpaaS ...
- Research Team
WOOD Daily: ING PW; JMT PL; BHW PW; BDX PW; MGROS TI; TBCG LN; CGEO LN...
HEADLINES: • ING BSK: 1Q25 results in line with expectations and our annual 2025E expectations NEUTRAL • Jeronimo Martins: beat in 1Q25; Biedronka margin stabilised, despite adverse calendar effect; FY25E guidance maintained POSITIVE • Bank Handlowy: dull 1Q25 results; dividend recommendation due later in May; uncertainty over impact of sale of retail operations persisting NEUTRAL • Budimex: 1Q25 EBITDA misses forecast slightly, backlog down marginally qoq, but rising amount of pending contracts...
MOL MOL NYRT
BHW BANK HANDLOWY W WARSZAWIE S.A.
BSK ING BANK SLASKI S.A.
BDX BUDIMEX S.A.
BFT BENEFIT SYSTEMS S.A. ALLOTMENT
MGROS MIGROS TICARET A.S
APR AUTO PARTNER SA
TBCB TBC BANK JOINT STOCK CO
CAR INTER CARS S.A.
BELA JUMBO S.A.
CGEO GEORGIA CAPITAL
ALG ALLEGRO.EU SA
CTPNV CTP NV
KLKIM KALEKIM KIMYEVI MADDELER SANAYI VE TICARET AS
ADNOCDRILL ADNOC DRILLING CO
DSPW DOOSAN SKODA POWER A.S.
DIAG DIAGNOSTYKA SA
- Thomas Vranken
Merus FIRST LOOK: 1Q25 results as expected, looking out toward ASCO up...
Merus announced its 1Q25 results, highlighting ongoing clinical trials and financial performance. The Ph2 trial of Peto in combination with Keytruda for head and neck cancer is progressing, with an update expected at ASCO 2025. The two Ph3 trials for head and neck cancer continue enrolling, with substantial enrolment expected by year-end 2025. With $ 638m in cash, Merus reiterates its cash runway into 2028. We reiterate our $ 59 TP/Buy.
- Hilde Van Boxstael
- Jacob Mekhael
- Michiel Declercq
- Thomas Vranken
- Wim Hoste
- Wim Lewi
- Wim Lewi
CTP 1Q25 results show good progress despite tariff war
Gross Rental income grew 15.9% yoy to EUR 182.5m vs. 178.6m expected (KBCS) and benefited from strong 4.2% like-for-like growth. The EPRA EPS of 0.21 came slightly above our expectation of 0.20. New leases signed increased 24% yoy at 3% higher rent. The FY25 EPS outlook is maintained at 0.86-0.88. The LTV% was flat at 45.3% vs. FY24 end. The Cost of Debt declined to 2.94% vs. 3.09% at FY24-end. The occupancy on standing assets was flat at 93% vs. FY24 end. CTP maintained its development pipeline...
- Jacob Mekhael
Zealand Pharma Uneventful 1Q25 results, dapi phase 1 higher dose data ...
Zealand reported uneventful 1Q25 results with a cash position of DKK 8,545m to be supplemented with a $1.4b (approx. DKK 9.24b) upfront from Roche in 2Q25. Pipeline timelines were reiterated, and while the later stage datasets are expected in 1H26, we look forward to results from the higher dose cohort from the phase 1b trial of dapiglutide (GLP-1/GLP-2 analog) in overweight/obese patients in 2Q25. In addition, we expect read-through from cagrisema's (GLP-1/amylin analog) full dataset potentiall...
- Wim Hoste
AB InBev FIRST LOOK: 1Q EBITDA +7.9%, FY guidance of 4-8% growth maint...
Despite (expected) 1Q top line weakness, ABI delivered a better than expected organic EBITDA performance, up 7.9% y/y. ABI reiterated FY25 guidance of 4-8% organic EBITDA growth which is in line with mid term guidance. We still see ABI as the undisputed leader in the beer space, with leading market shares in many markets, ongoing digitization and premiumization trends allowing to generate healthy free cash flows. Valuation remains attractive with EV/EBITDA25e at 9.2x and FCF yield25e at 7.7% and...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.